BACKGROUND: Recently, it has been reported that serum interleukin-1 beta (IL-1 beta), but not soluble IL-2 receptor (sIL-2R), concentrations were significantly higher in patients with posttraumatic stress disorder (PTSD) than in normal volunteers, and that psychological stress in humans is associated with increased secretion of proinflammatory cytokines, such as IL-6. METHODS: The aim of the present study was to examine the inflammatory response system in patients with PTSD through measurements of serum IL-6, sIL-6R, sgp130 (the IL-6 signal transducing protein), sIL-1R antagonist (sIL-1RA; an endogenous IL-1 receptor antagonist), CC16 (an endogenous anticytokine), and sCD8 (the T suppressor-cytotoxic antigen). RESULTS: Serum IL-6 and sIL-6R, but not sgp130, sIL-RA, CC16, or sCD8, concentrations were significantly higher in PTSD patients than in normal volunteers. Serum sIL-6R concentrations were significantly higher in PTSD patients with concurrent major depression than in PTSD patients without major depression and normal volunteers. There were no significant relationships between serum IL-6 or sIL-6R and severity measures of PTSD. CONCLUSIONS: The results suggest that PTSD is associated with increased IL-6 signaling. It is hypothesized that stress-induced secretion of proinflammatory cytokines is involved in the catecholaminergic modulation of anxiety reactions.
BACKGROUND: Recently, it has been reported that serum interleukin-1 beta (IL-1 beta), but not soluble IL-2 receptor (sIL-2R), concentrations were significantly higher in patients with posttraumatic stress disorder (PTSD) than in normal volunteers, and that psychological stress in humans is associated with increased secretion of proinflammatory cytokines, such as IL-6. METHODS: The aim of the present study was to examine the inflammatory response system in patients with PTSD through measurements of serum IL-6, sIL-6R, sgp130 (the IL-6 signal transducing protein), sIL-1R antagonist (sIL-1RA; an endogenous IL-1 receptor antagonist), CC16 (an endogenous anticytokine), and sCD8 (the T suppressor-cytotoxic antigen). RESULTS: Serum IL-6 and sIL-6R, but not sgp130, sIL-RA, CC16, or sCD8, concentrations were significantly higher in PTSDpatients than in normal volunteers. Serum sIL-6R concentrations were significantly higher in PTSDpatients with concurrent major depression than in PTSDpatients without major depression and normal volunteers. There were no significant relationships between serum IL-6 or sIL-6R and severity measures of PTSD. CONCLUSIONS: The results suggest that PTSD is associated with increased IL-6 signaling. It is hypothesized that stress-induced secretion of proinflammatory cytokines is involved in the catecholaminergic modulation of anxiety reactions.
Authors: Sian M J Hemmings; Stefanie Malan-Müller; Leigh L van den Heuvel; Brittany A Demmitt; Maggie A Stanislawski; David G Smith; Adam D Bohr; Christopher E Stamper; Embriette R Hyde; James T Morton; Clarisse A Marotz; Philip H Siebler; Maarten Braspenning; Wim Van Criekinge; Andrew J Hoisington; Lisa A Brenner; Teodor T Postolache; Matthew B McQueen; Kenneth S Krauter; Rob Knight; Soraya Seedat; Christopher A Lowry Journal: Psychosom Med Date: 2017-10 Impact factor: 4.312
Authors: Shveta V Parekh; Jacqueline E Paniccia; Christina L Lebonville; Donald T Lysle Journal: Psychopharmacology (Berl) Date: 2020-08-28 Impact factor: 4.530
Authors: Janice K Kiecolt-Glaser; Kristopher J Preacher; Robert C MacCallum; Cathie Atkinson; William B Malarkey; Ronald Glaser Journal: Proc Natl Acad Sci U S A Date: 2003-07-02 Impact factor: 11.205
Authors: Lilit P Hovhannisyan; Gohar M Mkrtchyan; Samvel H Sukiasian; Anna S Boyajyan Journal: Allergy Asthma Clin Immunol Date: 2010-02-21 Impact factor: 3.406
Authors: Satish A Eraly; Caroline M Nievergelt; Adam X Maihofer; Donald A Barkauskas; Nilima Biswas; Agorastos Agorastos; Daniel T O'Connor; Dewleen G Baker Journal: JAMA Psychiatry Date: 2014-04 Impact factor: 21.596
Authors: Alasdair George Sutherland; Gary A Cameron; David A Alexander; James D Hutchison Journal: Mediators Inflamm Date: 2008-12-22 Impact factor: 4.711